The correction is one of the largest in Abbott's recent continuous glucose monitor business, which dominates the global ...
Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp., in a deal with a total equity value of ...
Shares of Exact Sciences rose sharply Thursday after Abbott Laboratories agreed to purchase the cancer screening company in a ...
Abbott is moving to acquire Exact Sciences, a molecular diagnostics company that specializes in the detection of early-stage ...
Abbott Laboratories said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring sensors after internal testing showed some ...
Abbott Laboratories could be looking to acquire Exact Sciences, according to a report from Bloomberg, citing people close to ...
Abbott's $23B Exact Sciences deal adds short-term risk and earnings dilution. Click here to read what this means for ABT ...
Abbott Laboratories (NYSE: ABT) is one of the stocks Jim Cramer recently offered insights on. Cramer highlighted the ...
Big strategic acquisitions typically precede a return of venture capital to younger companies — a "flywheel" effect that ...
The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm infants have been consolidated.
Exact Sciences (EXAS) stock surges as Abbott Laboratories (ABT) agrees to acquire the company in a $21B all-cash acquisition.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback